Reduced employer coverage of weight loss drugs could push patients to cash-pay options or off treatment, increasing pressure on pharma companies to lower prices.
Doctors review AI advice that patients bring to appointments, but still have concerns about its accuracy. Healthcare marketers have room to help guide responsible genAI use.
They’re forging multibillion-dollar licensing and collaboration agreements to bolster drug pipelines as the US’ lead in drug development slips.
LinkedIn posts from digital health founders generate more engagement and AI citations than brand profiles, increasing visibility and discoverability beyond company pages.
US obesity is edging down as GLP-1 prescriptions climb, but high prices and low coverage may limit impact.
As consumers source wellness peptides via online retailers, social apps, and overseas sellers, regulated drugs and gray-market products may blur, elevating safety risks.
One-third of CFOs now rank health benefits among their top three operating concerns, and it’s driving cuts to coverage, hiring, and investment.
The US spends far more on prescription medicines than other developed nations and policy efforts are unlikely to narrow the gap.
Amazon should resist trying to disrupt US healthcare and instead focus on delivering a consumer-friendly care experience.
Healthcare membership buyers tend to skew younger, but a new GoodRx offering could tap a broader market of consumers losing coverage while still needing routine care.
Ad watchdog sides with pharma over misleading GLP-1 microdose telehealth marketing—but this scrutiny won't impact sales thanks to high consumer demand.
Oura's smart ring adds blood pressure signals, health records, and clinician chat—further blurring the line between wellness tools and healthcare tools.
It’s slowing adoption of health tools that could help those 65+ more effectively manage their health.
AI is becoming a common stop for second opinions after appointments, and the tech is influencing treatment decisions and follow-ups.
Pharma marketers are struggling to reach healthcare professionals through mass outreach, fueling demand for AI-powered personalization and specialty messaging in trusted HCP channels.
New deals add infectious disease research to its acquisition streak despite the government's mixed messages on vaccine policy.
Consumers want smarter digital health tools: This will push providers, insurers, and tech players to align with consumer demand for greater personalization, intuitiveness, and accurate health insights.
Teens lead in TikTok usage, per our estimates, but a new gov't advisory broadens scrutiny beyond social media, increasing pressure on tech safeguards and pediatric care.
Its roughly 30% average weight loss could expand options and accelerate a tiered treatment market ranging from oral pill convenience to surgical intervention for those with severe obesity.
They still see most health ads on linear TV and favor trusted medical sources. And while they avoid AI and social media for most health purposes, CTV is rising as a trusted digital channel.